The accuracy of disease characterization using Transcriptome Analysis depends on various factors, including the specific biomarker, the disease being targeted, and the stage of the disease.

Successful implementation of transcriptome analysis in personalized patient care requires interdisciplinary collaboration, robust infrastructure for data management and analysis, and continuous monitoring of the evolving field of transcriptomics.